WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) Stock Short Interest Report for October

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) was the target of a large growth in short interest in the month of October. As of October 30th, there was short interest totaling 66,851 shares, a growth of 498.5% from the October 15th total of 11,170 shares. Currently, 0.0% of the company’s shares are sold short. Based on an average daily trading volume, of 117,526 shares, the days-to-cover ratio is currently 0.6 days.

Analysts Set New Price Targets

Separately, Zacks Research raised WuXi Biologics (Cayman) to a “hold” rating in a research report on Friday, August 28th. One investment analyst has rated the stock with a Hold rating. According to data from MarketBeat, the stock currently has a consensus rating of “Hold”.

WuXi Biologics (Cayman) Trading Down 1.0%

OTCMKTS WXXWY traded down $0.12 during mid-day trading on Wednesday, hitting $12.32. The company’s stock had a trading volume of 11,685 shares, compared to its average volume of 69,463. WuXi Biologics has a 52-week low of $7.30 and a 52-week high of $14.80. The stock’s fifty day simple moving average is $12.77 and its two-hundred day simple moving average is $10.27.

WuXi Biologics (Cayman) Company Profile

WuXi Biologics (Cayman) Inc. is a contract research, development and manufacturing organization focused on biologic medicines. Founded in 2010, the company provides services to biotechnology and pharmaceutical companies developing treatments for patients worldwide. Its services span the biologics development process, including discovery, cell-line and process development, analytical testing, and clinical and commercial manufacturing. The company works with products such as monoclonal and multispecific antibodies, recombinant proteins, and antibody-drug conjugates.